Bottom line
GTHRX vs VHT: the short answer
GTHRX (INVESCO Health Care Fund) and VHT (Vanguard Health Care Index Fund) are both mutual funds.
But VHT is far broader, holding 407 positions to 82 for GTHRX, so beyond the top names it adds exposure GTHRX doesn't have.
VHT is cheaper at 0.09% vs 1.32% — a difference of $123 a year per $10,000 invested.
Over five years, VHT returned +7.2% a year vs +3.5% for GTHRX (reporting dates differ).
Updated Nov 19, 2026
GTHRX vs VHT side by side
| GTHRX | VHT | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Invesco | Vanguard |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.32% | 0.09% |
| Annual cost per $10k | $132 | $9 |
| 10-yr cost on $10k (prospectus) | $1,590 | $115 |
| Max front load | 0% | None |
| 12b-1 fee | 0.5% | 0% |
| 1-yr return | +15.2% | +2.7% |
| 5-yr return (annualized) | +3.5% | +7.2% |
| 10-yr return (annualized) | +6.1% | +8.8% |
| Best quarter | +19.6% | +16.5% |
| Worst quarter | −16.5% | −13.1% |
| Net assets (fund) | $1.2B | $19.0B |
| Number of holdings | 82 | 407 |
| Portfolio turnover | 59% | 4% |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | GTHRX | VHT | Difference |
|---|---|---|---|
| 2024 | +4.0% | +2.7% | +1.3% |
| 2023 | +3.1% | +2.5% | +0.6% |
| 2022 | −13.5% | −5.5% | −8.0% |
| 2021 | +12.2% | +20.5% | −8.3% |
| 2020 | +14.5% | +18.2% | −3.8% |
| 2019 | +32.0% | +22.0% | +10.0% |
| 2018 | +0.5% | +5.6% | −5.1% |
| 2017 | +15.5% | +23.3% | −7.9% |
| 2016 | −11.7% | −3.3% | −8.4% |
| 2015 | +3.0% | +7.2% | −4.2% |
Source: Fund prospectus bar charts
Holdings overlap
10 of GTHRX's top 25 holdings also appear in VHT's top 25.
| Holding | GTHRX | VHT |
|---|---|---|
| Eli Lilly and Co. | 10.59% | 14.04% |
| Johnson & Johnson | 6.76% | 8.47% |
| UnitedHealth Group Inc. | 6.17% | 5.45% |
| Merck & Co., Inc. | 4.59% | 4.66% |
| AbbVie Inc. | 4.03% | 6.09% |
| Gilead Sciences, Inc. | 3.63% | 2.64% |
| CVS Health Corp. | 2.52% | 1.83% |
| Vertex Pharmaceuticals Inc. | 2.01% | 1.80% |
| Edwards Lifesciences Corp. | 1.56% | 0.79% |
| Thermo Fisher Scientific Inc. | 1.55% | 2.93% |
Source: SEC Form N-PORT
GTHRX top 10
- Eli Lilly and Co. — 10.59%
- Johnson & Johnson — 6.76%
- UnitedHealth Group Inc. — 6.17%
- Invesco Private Prime Fund — 4.67%
- Merck & Co., Inc. — 4.59%
- AbbVie Inc. — 4.03%
- Gilead Sciences, Inc. — 3.63%
- argenx SE — 3.24%
- CVS Health Corp. — 2.52%
- Welltower Inc. — 2.34%
VHT top 10
- Eli Lilly & Co — 14.04%
- Johnson & Johnson — 8.47%
- AbbVie Inc — 6.09%
- UnitedHealth Group Inc — 5.45%
- Merck & Co Inc — 4.66%
- Thermo Fisher Scientific Inc — 2.93%
- Amgen Inc — 2.87%
- Gilead Sciences Inc — 2.64%
- Intuitive Surgical Inc — 2.38%
- Pfizer Inc — 2.35%
FAQ
What is the difference between GTHRX and VHT?
Which is cheaper, GTHRX or VHT?
Should I own both GTHRX and VHT?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.